1. Seddon J.M., Epidemiology of Age-Related Macular Degeneration (w:) Albert & Jakobiec, Principles and Practice of Ophthalmology, W.B.Saunders Company 2000, CD-ROM.

2. Seddon J.M., Hennekens C.H., Vitamins, minerals and macular degeneration. Arch Ophthalmol , 1994, 112, 176–179.

3. Mares-Perlman J.A., Millen A.E., Ficek T.L., Hankinson S.E., The Body of Evidence to Support a Protective Role for Lutein and Zeaxanthin in Delaying Chronic Disease. Overview, J Nutr, 2002, 132, 518S–524S.

4. Alves-Rodrigues A., Shao A., The science behind lutein, Toxicol Lett, 2004, 150, 57-83.

5. Broekmans W.M.R., Berendschot T.T.J.M., Klöpping-Ketelaars I.A.A., de Vries A.J., Goldbohm R.A., Tijburg L.B.M., Kardinaal A.F.M., van Poppel G., Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin, Am J Clin Nutr, 2002, 76, 595–603.

6. Hammond B.R.Jr, Ciulla T.A., Snodderly D.M., Macular Pigment Density Is Reduced in Obese Subjects, Invest Ophthalmol Vis Sci, 2002, 43, 47–50.

7. Sunness J., Bressler N., Tian Y., The enlargement of geographic atrophy over time in age-related macular degeneration, Invest Ophthalmol Vis Sci, 1996, 37, 21-25.

8. Niżankowska M.H., Choroby siatkówki. (w:) Podstawy okulistyki. Volumed. Wrocław. 1993; 231 – 233.

9. Kański J., Zwyrodnienia i dystrofie dna oka (w :) Okulistyka Kliniczna. Urban&Partner. Wrocław, 1997, 390 – 397.

10. Zarbin M.A., Age-related macular degeneration: review of pathogenesis, Eur J Ophthalmol, 1998, 8,: 199-206.

11. Semba R.D., Dagnelie G., Are lutein and zeaxanthin conditionally essential nutrients for eye health?, Med Hypotheses, 2003, 61, 465-472. 12. Beatty S., Boulton M., Henson D., Koh H.H., Murray I.J., Macular pigment and age related macular degeneration, Br J Ophthalmol, 1999, 83, 867–877.

13. Richter S., Stiles W., Statkute L., Pulido J., Frankowski J., Rudy D., Pei K., Tsipursky M., Nyland J., Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial), Optometry, 2004, 75, 216-230.

14. Koh H.H., Murray I.J., Nolan D, i wsp. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study, Exp Eye Res, 2004, 79, 21-27.

15. Age-Related Eye Disease Study Research Group, A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age- Related Macular Degeneration and Vision Loss: AREDS Report No. 8, Arch Ophthalmol, 2001, 119, 1417-1436.

16. Jacques P.F., Chylack L.T.Jr., Hankinson S.E., Khu P.M., Rogers G., Friend J., Tung W., Wolfe J.K., Padhye N., Willett W.C., Taylor A., Long-term nutrient intake and early age-related nuclear lens opacities, Arch Ophthalmol, 2001, 119, 1009-1019.

17. Christen W.G., Liu S., Glynn R.J., Gaziano J.M., Buring J.E., Dietary Carotenoids, Vitamins C and F, and Risk of Cataract Women, Archives of Ophthalmology, 2008, 126, 1, 102.

18. Dilsiz N., Sahaboglu A., Yildiz M.Z., Reichenbach A.: Protective effects of various antioxidants during ischemia-reperfusion in the rat retina, Graefe's Archive for Clinical and Experimental Ophthalmology, 2006, 244, 5, 627.

19. Dwyer J.H., Navab M., Dwyer K.M., Hassan K., Sun P., Shircore A.,Hama-Levy S., Hough G., Wang X., Drake T., Merz C.N., Fogelman A.M., Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study, Circulation, 2001, 103, 2922–2927.

20. Street D.A., Comstock G.W., Salkeld R.M., Schuep W., Klag M.J., Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction?, Circulation, 1994, 90, 1154-1161.

21. Hirvonen T., Virtamo J., Korhonen P., Albanes D., Pietinen P, Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers, Stroke, 2000, 31, 2301-2306.

22. O'Connor I., O'Brien N., Modulation of UVA light-induced oxidative stress by beta-carotene, lutein and astaxanthin in cultured fibroblasts, J Dermatol Sci, 1998, 16, 226-230.

23. Lee E.H., Faulhaber D., Hanson K.M., Ding W., Peters S., Kodali S., Granstein R.D.: Dietary lutein reduces ultraviolet radiationinduced inflammation and immunosuppression, J Invest Dermatol, 2004, 122, 510-517.

24. Dwyer J.H., Navab M., Dwyer K.M., Hassan K., Sun P., Shircore A., Hama-Levy S., Hough G., Wang X., Drake T., Merz C.N., Fogelman A.M., Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study, Circulation, 2001, 103, 2922-2927.